| Product NDC: | 52959-014 |
| Proprietary Name: | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Non Proprietary Name: | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Active Ingredient(s): | 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g & nbsp; Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52959-014 |
| Labeler Name: | H.J. Harkins Company, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100106 |
| Package NDC: | 52959-014-03 |
| Package Description: | 28.34 g in 1 TUBE (52959-014-03) |
| NDC Code | 52959-014-03 |
| Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Package Description | 28.34 g in 1 TUBE (52959-014-03) |
| Product NDC | 52959-014 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20100106 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 5; 5000 |
| Strength Unit | [USP'U]/g; mg/g; [USP'U]/g |
| Pharmaceutical Classes |